Oramed Pharmaceuticals, Inc. (ORMP)
3.42
+0.03
(+0.88%)
USD |
NASDAQ |
Apr 02, 16:00
3.42
0.00 (0.00%)
Pre-Market: 20:00
Oramed Pharmaceuticals EPS Diluted (Quarterly) : 0.2274 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lifeward Ltd. | -3.595 |
| Bristol Myers Squibb Co. | 0.5326 |
| Merck & Co., Inc. | 1.191 |
| Instil Bio, Inc. | -1.208 |
| Moderna, Inc. | -2.107 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.201M |
| Total Expenses (Quarterly) | -9.201M |
| Enterprise Value | 13.26M |
| Earnings Yield | 43.05% |
| Normalized Earnings Yield | 22.04 |